VAN STEEN Bartholomeus Johannes
No ORCID on file
· 20 papers in corpus
· active 2005-2006
Frequent coauthors
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2006
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…
2005
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing the…